Value of mesothelin immunostaining in the diagnosis of mesothelioma.
about
Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancerMesothelin targeted cancer immunotherapyCharacterization of human mesothelin transcripts in ovarian and pancreatic cancerClinical impacts of mesothelin expression in gastrointestinal carcinomasMalignant peritoneal mesothelioma presented as peritoneal adenocarcinoma or primary ovarian cancer: case series and review of the clinical and immunohistochemical featuresRecognition of Mesothelin by the Therapeutic Antibody MORAb-009: STRUCTURAL AND MECHANISTIC INSIGHTSAberrant splicing and protease involvement in mesothelin release from epithelioid mesothelioma cellsManagement of malignant mesothelioma by decortication and adjunct phototherapy.Folate receptor alpha, mesothelin and megakaryocyte potentiating factor as potential serum markers of chronic kidney disease.Mesothelin Immunotherapy for Cancer: Ready for Prime Time?Inhibition of mesothelin-CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy.Re-evaluation of histological diagnoses of malignant mesothelioma by immunohistochemistry.Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin.Investigational approaches for mesothelioma.Efficacy of RG7787, a next-generation mesothelin-targeted immunotoxin, against triple-negative breast and gastric cancers.Phase II clinical trial of amatuximab, a chimeric antimesothelin antibody with pemetrexed and cisplatin in advanced unresectable pleural mesotheliomaMesothelin expression is associated with poor outcomes in breast cancer.Phase I clinical trial of the chimeric anti-mesothelin monoclonal antibody MORAb-009 in patients with mesothelin-expressing cancers.Novel immunocytokine IL12-SS1 (Fv) inhibits mesothelioma tumor growth in nude mice.Expansion of anti-mesothelin specific CD4+ and CD8+ T cell responses in patients with pancreatic carcinoma.Chemotherapy and targeted therapies for unresectable malignant mesotheliomaImportance of luminal membrane mesothelin expression in intraductal papillary mucinous neoplasms.The hen model of human ovarian cancer develops anti-mesothelin autoantibodies in response to mesothelin expressing tumors.Cytotoxic activity of immunotoxin SS1P is modulated by TACE-dependent mesothelin shedding.Phase I study of amatuximab, a novel monoclonal antibody to mesothelin, in Japanese patients with advanced solid tumors.A novel PET imaging using ⁶⁴Cu-labeled monoclonal antibody against mesothelin commonly expressed on cancer cellsHigh mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosis.Mesothelin-targeted agents in clinical trials and in preclinical development.Establishment of anti-mesothelioma monoclonal antibodiesLuminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancerIdentification of glycoproteins associated with different histological subtypes of ovarian tumors using quantitative glycoproteomics.Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma.Soluble mesothelin-related protein in pleural effusion from patients with malignant pleural mesotheliomaRecent Advances in the Development of Antineoplastic Agents Derived from Natural ProductsThe role of mesothelin in tumor progression and targeted therapy.Mesothelin regulates growth and apoptosis in pancreatic cancer cells through p53-dependent and -independent signal pathwayAnticancer Effects of Mesothelin-Targeted Immunotoxin Therapy Are Regulated by Tyrosine Kinase DDR1.Mesothelin Expression in Advanced Gastroesophageal Cancer Represents a Novel Target for Immunotherapy.Serum folate receptor alpha, mesothelin and megakaryocyte potentiating factor in ovarian cancer: association to disease stage and grade and comparison to CA125 and HE4.Mesothelin expression is a prognostic factor in cholangiocellular carcinoma.
P2860
Q24622837-46661E4B-28B2-4F4D-9999-8210BA52DEA7Q24656242-88377EE3-3E92-4F95-AA65-3759792EE6F1Q24791193-7E263849-AF6C-4E0D-A8F2-699AF543E962Q26748680-F40D4167-CA85-4769-A55A-B53D887E85FFQ27024213-63EAC06C-8698-4BA7-BCC3-DF5E55A31662Q27670713-591C37A5-2CCC-47F2-9ED7-FD9018272F3DQ28263206-1A78177E-9207-40E8-8128-8FBF17E80E51Q33244201-3630B331-5D95-425C-A57D-668A663A550CQ33734661-91B13CA0-BD9A-4BE0-9F27-D9072027AAACQ33816551-1F5BCC83-B636-4230-886F-70202D2EB0C8Q33828838-03CB7E29-5E32-470A-97FB-0B32355F3EA5Q34043710-9D13F8A7-7977-4AE4-8DAA-3830D4E97BCCQ34111770-743699F7-98A6-4966-8D8E-22589B3C3C81Q34293068-4AB30823-7747-4ED3-B8BC-6B562924AF79Q34459015-FE0BDFEE-307B-411D-9F25-040A009A5EDCQ34614847-0394BBA9-4B48-4BB0-81D4-7CDBD296C374Q34669372-A2791158-CFC7-4A2B-B328-0EAE23F41A52Q34676443-85807D52-D9EB-40F4-88CA-9CF549E34AF2Q35049589-2FFDC3D6-709A-4C35-99B3-A7FDECF4AB6FQ35092711-F57C9D1F-0E3D-4A09-92D8-DC598B8BCC25Q35141369-EBF18CF0-C806-4D9B-BF83-39D81A8435FBQ35167481-8168E1C4-7581-41BC-97E4-FF2AE3DB5151Q35185032-77F44BB7-FEE7-42FF-BBFB-4838C5CA15FDQ35190612-0FABD27E-41BD-48A4-9F1D-AEE095A8CEDEQ35288837-87DFED5C-AD76-4F20-84D1-A42A29F258FDQ35323396-7486D8CA-ACC5-49D1-8300-051D26A2F3A7Q35793906-B24FB0C5-EED3-45ED-B0BD-D755A4EC2CBBQ35815380-5E14EFDC-9DCD-411F-A5FC-B125FD50C602Q36061312-01BD3CEF-3ECD-496B-B0FD-E208344EE320Q36075289-DC1E17EE-D4CA-4235-9ABD-D89E31D6BB74Q36184966-FAA46308-CC70-46FE-9A4C-EC538C511A89Q36225781-4F1F98F6-0E95-404A-8619-B8EDB4281F5BQ36244087-B50EA13B-4C10-4A61-B1AE-9C6AE7FD212BQ36273796-5BCC9CBC-4832-4829-8DC2-3142A4B41D64Q36597831-676F93F9-F8BF-432A-B689-B8120811D8A6Q36649265-6E665B58-B12C-4893-A637-C93F591CECB7Q36693123-869191C1-9709-4D8F-A717-056D08E52A47Q36767781-486CABC8-0C8A-4B50-81DC-22B12AF2C66CQ36808757-7DAF918A-88B1-492F-AA70-094BE7DAB0C7Q37044754-49F0D7E4-A3E7-452A-8567-2B57D7103A8F
P2860
Value of mesothelin immunostaining in the diagnosis of mesothelioma.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Value of mesothelin immunostaining in the diagnosis of mesothelioma.
@en
Value of mesothelin immunostaining in the diagnosis of mesothelioma.
@nl
type
label
Value of mesothelin immunostaining in the diagnosis of mesothelioma.
@en
Value of mesothelin immunostaining in the diagnosis of mesothelioma.
@nl
prefLabel
Value of mesothelin immunostaining in the diagnosis of mesothelioma.
@en
Value of mesothelin immunostaining in the diagnosis of mesothelioma.
@nl
P1433
P1476
Value of mesothelin immunostaining in the diagnosis of mesothelioma.
@en
P2093
Nelson G Ordóñez
P304
P356
10.1097/01.MP.0000056981.16578.C3
P577
2003-03-01T00:00:00Z
P6179
1015499174